Alok Singh
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 7 | 2024 | 250 | 2.320 |
Why?
| | Mycobacterium tuberculosis | 10 | 2025 | 312 | 1.650 |
Why?
| | Leishmania donovani | 4 | 2016 | 12 | 1.520 |
Why?
| | Tuberculosis | 7 | 2023 | 279 | 1.320 |
Why?
| | BCG Vaccine | 4 | 2022 | 24 | 1.290 |
Why?
| | Carboxylic Acids | 4 | 2013 | 34 | 1.210 |
Why?
| | Antitubercular Agents | 4 | 2025 | 203 | 1.170 |
Why?
| | Neurocysticercosis | 2 | 2018 | 8 | 1.130 |
Why?
| | Macrophages | 9 | 2023 | 1541 | 0.980 |
Why?
| | Dinucleoside Phosphates | 2 | 2022 | 27 | 0.920 |
Why?
| | Gastric Outlet Obstruction | 1 | 2024 | 11 | 0.900 |
Why?
| | Self Expandable Metallic Stents | 1 | 2024 | 16 | 0.890 |
Why?
| | Mycobacterium bovis | 2 | 2021 | 16 | 0.890 |
Why?
| | Seizures | 2 | 2018 | 430 | 0.870 |
Why?
| | Refuse Disposal | 1 | 2023 | 4 | 0.850 |
Why?
| | Waste Management | 1 | 2023 | 10 | 0.850 |
Why?
| | Gallstones | 1 | 2023 | 31 | 0.850 |
Why?
| | Antiemetics | 1 | 2024 | 43 | 0.840 |
Why?
| | Oxygen | 3 | 2013 | 933 | 0.810 |
Why?
| | Mite Infestations | 2 | 2020 | 8 | 0.800 |
Why?
| | Titanium | 3 | 2012 | 82 | 0.780 |
Why?
| | Virus Diseases | 2 | 2022 | 214 | 0.770 |
Why?
| | Dog Diseases | 2 | 2020 | 62 | 0.760 |
Why?
| | Tuberculosis Vaccines | 1 | 2021 | 5 | 0.750 |
Why?
| | Myopia | 1 | 2022 | 47 | 0.730 |
Why?
| | Nomograms | 1 | 2022 | 54 | 0.720 |
Why?
| | Onium Compounds | 2 | 2017 | 9 | 0.710 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2021 | 66 | 0.690 |
Why?
| | Blood-Brain Barrier | 2 | 2021 | 140 | 0.680 |
Why?
| | Ivermectin | 1 | 2020 | 13 | 0.680 |
Why?
| | Cancer Vaccines | 1 | 2022 | 173 | 0.670 |
Why?
| | Cytokines | 5 | 2022 | 2088 | 0.660 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2017 | 58 | 0.660 |
Why?
| | Deglutition | 1 | 2020 | 72 | 0.660 |
Why?
| | Hypogonadism | 1 | 2020 | 88 | 0.650 |
Why?
| | Mites | 1 | 2019 | 7 | 0.640 |
Why?
| | Cardiovascular Diseases | 7 | 2025 | 2108 | 0.630 |
Why?
| | Stents | 1 | 2023 | 528 | 0.630 |
Why?
| | Immunity, Cellular | 1 | 2021 | 268 | 0.630 |
Why?
| | Glucose Intolerance | 1 | 2020 | 146 | 0.610 |
Why?
| | Nanostructures | 3 | 2024 | 108 | 0.600 |
Why?
| | Deglutition Disorders | 1 | 2020 | 143 | 0.590 |
Why?
| | Schiff Bases | 3 | 2012 | 7 | 0.580 |
Why?
| | Pyrazoles | 2 | 2021 | 423 | 0.580 |
Why?
| | Mannich Bases | 1 | 2017 | 1 | 0.570 |
Why?
| | Autophagy | 2 | 2020 | 281 | 0.570 |
Why?
| | Curcumin | 1 | 2017 | 29 | 0.550 |
Why?
| | Glycolipids | 1 | 2017 | 42 | 0.540 |
Why?
| | Antineoplastic Agents | 3 | 2024 | 2129 | 0.530 |
Why?
| | Anti-Bacterial Agents | 5 | 2019 | 1799 | 0.520 |
Why?
| | Mycobacterium Infections, Nontuberculous | 2 | 2021 | 360 | 0.520 |
Why?
| | Image Enhancement | 1 | 2018 | 190 | 0.520 |
Why?
| | Leishmaniasis, Visceral | 1 | 2016 | 22 | 0.510 |
Why?
| | Spectrophotometry, Infrared | 7 | 2013 | 54 | 0.510 |
Why?
| | Humans | 58 | 2025 | 136783 | 0.510 |
Why?
| | Positron-Emission Tomography | 4 | 2025 | 295 | 0.510 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2016 | 78 | 0.500 |
Why?
| | X-Ray Diffraction | 7 | 2013 | 104 | 0.500 |
Why?
| | Animals | 35 | 2025 | 36768 | 0.500 |
Why?
| | Multiple Sclerosis | 1 | 2021 | 456 | 0.480 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2017 | 204 | 0.480 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 359 | 0.470 |
Why?
| | Contrast Media | 1 | 2018 | 462 | 0.460 |
Why?
| | Eflornithine | 1 | 2014 | 6 | 0.440 |
Why?
| | Drug Resistance | 2 | 2014 | 169 | 0.440 |
Why?
| | Host-Pathogen Interactions | 2 | 2017 | 364 | 0.430 |
Why?
| | Gene Expression Profiling | 3 | 2016 | 1768 | 0.420 |
Why?
| | Brain | 4 | 2018 | 2669 | 0.420 |
Why?
| | T-Lymphocytes | 2 | 2021 | 1998 | 0.420 |
Why?
| | Metabolic Diseases | 2 | 2025 | 108 | 0.420 |
Why?
| | Iron Compounds | 1 | 2013 | 6 | 0.420 |
Why?
| | Metals | 2 | 2014 | 137 | 0.410 |
Why?
| | Insulin Resistance | 2 | 2024 | 1201 | 0.400 |
Why?
| | Lipid Metabolism | 1 | 2016 | 512 | 0.400 |
Why?
| | Proteome | 2 | 2015 | 472 | 0.400 |
Why?
| | Organometallic Compounds | 2 | 2014 | 111 | 0.400 |
Why?
| | Coordination Complexes | 1 | 2012 | 13 | 0.390 |
Why?
| | Staphylococcus aureus | 4 | 2019 | 452 | 0.390 |
Why?
| | Oxides | 1 | 2012 | 45 | 0.380 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 200 | 0.370 |
Why?
| | Urothelium | 2 | 2022 | 37 | 0.370 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2024 | 211 | 0.370 |
Why?
| | Genes, BRCA1 | 1 | 2011 | 38 | 0.370 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2025 | 141 | 0.370 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 618 | 0.370 |
Why?
| | Apoptosis | 5 | 2025 | 2548 | 0.360 |
Why?
| | Particle Size | 2 | 2010 | 394 | 0.360 |
Why?
| | HIV Infections | 3 | 2022 | 2812 | 0.360 |
Why?
| | Aziridines | 1 | 2011 | 5 | 0.360 |
Why?
| | Iron | 2 | 2016 | 311 | 0.350 |
Why?
| | Aza Compounds | 1 | 2011 | 14 | 0.350 |
Why?
| | MicroRNAs | 2 | 2024 | 697 | 0.350 |
Why?
| | Epigenomics | 1 | 2011 | 115 | 0.350 |
Why?
| | Gene Silencing | 1 | 2011 | 193 | 0.340 |
Why?
| | Carbohydrates | 1 | 2011 | 66 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 5 | 2018 | 3566 | 0.340 |
Why?
| | Membrane Proteins | 3 | 2022 | 1162 | 0.340 |
Why?
| | Proteomics | 2 | 2015 | 1108 | 0.340 |
Why?
| | Enzyme Inhibitors | 4 | 2019 | 838 | 0.330 |
Why?
| | Breast Neoplasms | 3 | 2011 | 2239 | 0.330 |
Why?
| | Monocytes | 2 | 2016 | 561 | 0.330 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4279 | 0.330 |
Why?
| | Thorium | 1 | 2009 | 1 | 0.320 |
Why?
| | Fluorescent Dyes | 2 | 2025 | 318 | 0.320 |
Why?
| | Mice | 16 | 2025 | 17731 | 0.310 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2010 | 130 | 0.310 |
Why?
| | Death, Sudden, Cardiac | 1 | 2010 | 184 | 0.290 |
Why?
| | Population Surveillance | 1 | 2011 | 470 | 0.290 |
Why?
| | Microbial Viability | 2 | 2019 | 91 | 0.280 |
Why?
| | Models, Chemical | 1 | 2009 | 268 | 0.280 |
Why?
| | Immunity, Innate | 3 | 2023 | 826 | 0.280 |
Why?
| | Bacterial Load | 2 | 2017 | 68 | 0.280 |
Why?
| | Young Adult | 5 | 2024 | 13126 | 0.270 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 2512 | 0.270 |
Why?
| | Sports | 1 | 2010 | 230 | 0.270 |
Why?
| | Neoplasms | 3 | 2023 | 2644 | 0.260 |
Why?
| | Microbial Sensitivity Tests | 3 | 2017 | 356 | 0.260 |
Why?
| | Organoids | 2 | 2018 | 111 | 0.260 |
Why?
| | Plant Diseases | 2 | 2024 | 44 | 0.260 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 696 | 0.260 |
Why?
| | India | 4 | 2025 | 193 | 0.260 |
Why?
| | Enterobacter cloacae | 1 | 2025 | 5 | 0.250 |
Why?
| | Dysbiosis | 2 | 2025 | 180 | 0.250 |
Why?
| | Phage Therapy | 1 | 2025 | 15 | 0.240 |
Why?
| | Adult | 10 | 2024 | 37616 | 0.240 |
Why?
| | Lipid Droplets | 1 | 2025 | 23 | 0.240 |
Why?
| | Enterobacteriaceae Infections | 1 | 2025 | 43 | 0.240 |
Why?
| | Dogs | 3 | 2024 | 409 | 0.230 |
Why?
| | Urbanization | 1 | 2025 | 29 | 0.230 |
Why?
| | Trichoderma | 1 | 2024 | 28 | 0.230 |
Why?
| | Female | 20 | 2025 | 72840 | 0.230 |
Why?
| | Water | 2 | 2025 | 463 | 0.230 |
Why?
| | Aniline Compounds | 1 | 2025 | 102 | 0.220 |
Why?
| | Recurrence | 2 | 2018 | 1058 | 0.220 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3709 | 0.220 |
Why?
| | Cell Line, Tumor | 4 | 2024 | 3399 | 0.220 |
Why?
| | Extreme Heat | 1 | 2024 | 6 | 0.220 |
Why?
| | Moringa oleifera | 1 | 2023 | 3 | 0.220 |
Why?
| | Environmental Monitoring | 2 | 2023 | 369 | 0.220 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2024 | 19 | 0.220 |
Why?
| | Imidazoles | 1 | 2025 | 239 | 0.220 |
Why?
| | Bacteriophages | 1 | 2025 | 95 | 0.220 |
Why?
| | Solid Waste | 1 | 2023 | 3 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2025 | 233 | 0.210 |
Why?
| | Glutamine | 1 | 2024 | 104 | 0.210 |
Why?
| | Prospective Studies | 3 | 2024 | 7583 | 0.210 |
Why?
| | Cold Temperature | 1 | 2025 | 177 | 0.210 |
Why?
| | Nausea | 1 | 2024 | 111 | 0.210 |
Why?
| | Middle Aged | 9 | 2024 | 33200 | 0.210 |
Why?
| | Cognition Disorders | 2 | 2018 | 515 | 0.210 |
Why?
| | Cholecystectomy | 1 | 2023 | 60 | 0.210 |
Why?
| | Drug Repositioning | 3 | 2019 | 35 | 0.210 |
Why?
| | Nanoparticles | 1 | 2009 | 484 | 0.210 |
Why?
| | Urinary Tract Infections | 1 | 2025 | 168 | 0.210 |
Why?
| | Risk Reduction Behavior | 1 | 2025 | 218 | 0.210 |
Why?
| | Pancreatitis | 1 | 2024 | 132 | 0.210 |
Why?
| | Vomiting | 1 | 2024 | 129 | 0.210 |
Why?
| | Cities | 1 | 2023 | 131 | 0.200 |
Why?
| | Spectroscopy, Mossbauer | 2 | 2013 | 2 | 0.200 |
Why?
| | Aging | 2 | 2018 | 1861 | 0.200 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2012 | 616 | 0.200 |
Why?
| | Powders | 3 | 2012 | 43 | 0.200 |
Why?
| | Heat Stress Disorders | 1 | 2024 | 75 | 0.200 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 671 | 0.200 |
Why?
| | Climate Change | 1 | 2025 | 182 | 0.200 |
Why?
| | Pancreas | 2 | 2024 | 328 | 0.200 |
Why?
| | Life Style | 1 | 2025 | 484 | 0.200 |
Why?
| | Ligands | 4 | 2012 | 664 | 0.200 |
Why?
| | Chromatography, Liquid | 2 | 2015 | 432 | 0.190 |
Why?
| | Electrons | 3 | 2012 | 85 | 0.190 |
Why?
| | Kinetics | 4 | 2023 | 1668 | 0.190 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2022 | 7 | 0.190 |
Why?
| | Cardiovascular System | 1 | 2024 | 139 | 0.190 |
Why?
| | Soil Microbiology | 1 | 2024 | 218 | 0.190 |
Why?
| | Ketones | 2 | 2012 | 49 | 0.190 |
Why?
| | Vero Cells | 2 | 2021 | 67 | 0.190 |
Why?
| | Pacinian Corpuscles | 1 | 2021 | 1 | 0.180 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2024 | 198 | 0.180 |
Why?
| | Dexamethasone | 1 | 2024 | 377 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2022 | 96 | 0.180 |
Why?
| | Optical Imaging | 2 | 2025 | 61 | 0.180 |
Why?
| | Receptor, trkB | 1 | 2021 | 33 | 0.180 |
Why?
| | Acetamides | 1 | 2021 | 36 | 0.180 |
Why?
| | Adolescent | 6 | 2022 | 21463 | 0.180 |
Why?
| | Mass Spectrometry | 3 | 2014 | 739 | 0.180 |
Why?
| | Male | 12 | 2024 | 67361 | 0.180 |
Why?
| | Sulfonamides | 1 | 2025 | 512 | 0.180 |
Why?
| | Deficiency Diseases | 1 | 2020 | 10 | 0.180 |
Why?
| | Iodine Radioisotopes | 1 | 2021 | 145 | 0.180 |
Why?
| | Retinal Ganglion Cells | 1 | 2022 | 110 | 0.180 |
Why?
| | Permeability | 1 | 2021 | 162 | 0.170 |
Why?
| | Diverticulum, Esophageal | 1 | 2020 | 4 | 0.170 |
Why?
| | Myeloid Cells | 1 | 2022 | 147 | 0.170 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1267 | 0.170 |
Why?
| | Water Pollutants, Chemical | 1 | 2023 | 216 | 0.170 |
Why?
| | Pyrimidines | 2 | 2021 | 470 | 0.170 |
Why?
| | Radiation Dosage | 1 | 2021 | 173 | 0.170 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 27 | 0.170 |
Why?
| | History, 21st Century | 1 | 2021 | 211 | 0.170 |
Why?
| | Staphylococcal Infections | 4 | 2019 | 401 | 0.170 |
Why?
| | CD4 Antigens | 2 | 2017 | 141 | 0.170 |
Why?
| | Tomography, Optical Coherence | 1 | 2022 | 212 | 0.160 |
Why?
| | Drug Discovery | 2 | 2018 | 141 | 0.160 |
Why?
| | Drug Synergism | 2 | 2017 | 378 | 0.160 |
Why?
| | Cell Line | 2 | 2016 | 2836 | 0.160 |
Why?
| | History, 20th Century | 1 | 2021 | 323 | 0.160 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 282 | 0.160 |
Why?
| | Rats | 4 | 2022 | 5628 | 0.160 |
Why?
| | Diarylquinolines | 1 | 2019 | 13 | 0.160 |
Why?
| | Caspases | 1 | 2020 | 247 | 0.160 |
Why?
| | Whole Body Imaging | 1 | 2019 | 25 | 0.160 |
Why?
| | Genome, Bacterial | 1 | 2020 | 142 | 0.160 |
Why?
| | Molecular Structure | 3 | 2025 | 495 | 0.160 |
Why?
| | Granulosa Cells | 1 | 2019 | 33 | 0.160 |
Why?
| | Pyruvates | 1 | 2019 | 24 | 0.160 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2023 | 86 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 185 | 0.150 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 364 | 0.150 |
Why?
| | Vitamin D Deficiency | 1 | 2020 | 184 | 0.150 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 188 | 0.150 |
Why?
| | Fasting | 1 | 2020 | 278 | 0.150 |
Why?
| | Oocytes | 1 | 2019 | 175 | 0.150 |
Why?
| | Child | 6 | 2024 | 21968 | 0.140 |
Why?
| | Thienamycins | 1 | 2017 | 5 | 0.140 |
Why?
| | Botrytis | 1 | 2017 | 2 | 0.140 |
Why?
| | Cicer | 1 | 2017 | 2 | 0.140 |
Why?
| | Mycobacterium marinum | 1 | 2017 | 3 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 467 | 0.140 |
Why?
| | Mycobacterium leprae | 1 | 2017 | 8 | 0.140 |
Why?
| | Gene Expression | 2 | 2020 | 1499 | 0.140 |
Why?
| | Amikacin | 1 | 2017 | 23 | 0.140 |
Why?
| | Ethambutol | 1 | 2017 | 26 | 0.140 |
Why?
| | Basidiomycota | 1 | 2017 | 29 | 0.140 |
Why?
| | Gene Expression Regulation | 2 | 2018 | 2603 | 0.140 |
Why?
| | Leprosy | 1 | 2017 | 24 | 0.140 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2018 | 132 | 0.140 |
Why?
| | Thymocytes | 1 | 2017 | 35 | 0.140 |
Why?
| | Ruthenium | 2 | 2014 | 34 | 0.140 |
Why?
| | Obesity | 1 | 2011 | 2975 | 0.140 |
Why?
| | Brain Mapping | 2 | 2018 | 504 | 0.140 |
Why?
| | HIV | 1 | 2018 | 233 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 267 | 0.140 |
Why?
| | Brain Edema | 1 | 2017 | 61 | 0.140 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2017 | 71 | 0.140 |
Why?
| | Blood Glucose | 2 | 2020 | 2180 | 0.140 |
Why?
| | Immune Evasion | 1 | 2017 | 58 | 0.140 |
Why?
| | Immunization | 1 | 2019 | 410 | 0.130 |
Why?
| | Disease | 1 | 2018 | 98 | 0.130 |
Why?
| | Forkhead Transcription Factors | 1 | 2018 | 190 | 0.130 |
Why?
| | Amino Acids | 1 | 2020 | 500 | 0.130 |
Why?
| | Learning | 1 | 2021 | 414 | 0.130 |
Why?
| | Demyelinating Diseases | 1 | 2017 | 85 | 0.130 |
Why?
| | Neutropenia | 1 | 2017 | 146 | 0.130 |
Why?
| | Immunotherapy | 1 | 2021 | 640 | 0.130 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 95 | 0.130 |
Why?
| | Chloride Channel Agonists | 1 | 2017 | 84 | 0.130 |
Why?
| | Beclin-1 | 1 | 2016 | 11 | 0.130 |
Why?
| | Arsenic | 1 | 2017 | 65 | 0.130 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2016 | 13 | 0.130 |
Why?
| | Prostatic Neoplasms | 1 | 2024 | 1031 | 0.130 |
Why?
| | Drug Combinations | 1 | 2017 | 344 | 0.130 |
Why?
| | Autophagy-Related Proteins | 1 | 2016 | 46 | 0.130 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2017 | 93 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 532 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 624 | 0.130 |
Why?
| | Ions | 1 | 2016 | 71 | 0.130 |
Why?
| | Signal Transduction | 4 | 2021 | 5065 | 0.120 |
Why?
| | Aged | 4 | 2024 | 23729 | 0.120 |
Why?
| | Hypertension | 1 | 2025 | 1284 | 0.120 |
Why?
| | Parasites | 1 | 2016 | 47 | 0.120 |
Why?
| | Oxidative Stress | 3 | 2019 | 1309 | 0.120 |
Why?
| | Up-Regulation | 2 | 2016 | 843 | 0.120 |
Why?
| | Quinolones | 1 | 2017 | 137 | 0.120 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 913 | 0.120 |
Why?
| | Urinary Bladder | 1 | 2017 | 185 | 0.120 |
Why?
| | Oryza | 2 | 2014 | 33 | 0.120 |
Why?
| | Aminophenols | 1 | 2017 | 156 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2024 | 10764 | 0.120 |
Why?
| | Neuroimaging | 1 | 2017 | 263 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1055 | 0.120 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 891 | 0.120 |
Why?
| | Glycoside Hydrolase Inhibitors | 1 | 2014 | 1 | 0.120 |
Why?
| | alpha-Glucosidases | 1 | 2014 | 9 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 1 | 2017 | 425 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2016 | 495 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 2 | 2014 | 168 | 0.110 |
Why?
| | Electroencephalography | 1 | 2017 | 433 | 0.110 |
Why?
| | Logistic Models | 2 | 2017 | 2060 | 0.110 |
Why?
| | Pyridines | 2 | 2018 | 505 | 0.110 |
Why?
| | Palladium | 1 | 2014 | 17 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2020 | 3537 | 0.110 |
Why?
| | Immunoblotting | 1 | 2015 | 307 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 387 | 0.110 |
Why?
| | Ornithine Decarboxylase | 1 | 2014 | 10 | 0.110 |
Why?
| | Subcellular Fractions | 1 | 2014 | 82 | 0.110 |
Why?
| | Spermidine | 1 | 2014 | 19 | 0.110 |
Why?
| | Polyamines | 1 | 2014 | 40 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 343 | 0.110 |
Why?
| | Free Radicals | 1 | 2014 | 108 | 0.110 |
Why?
| | Antioxidants | 1 | 2017 | 578 | 0.110 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2011 | 152 | 0.110 |
Why?
| | Body Mass Index | 2 | 2013 | 2364 | 0.110 |
Why?
| | GTP Phosphohydrolases | 1 | 2014 | 92 | 0.100 |
Why?
| | Agriculture | 2 | 2024 | 101 | 0.100 |
Why?
| | Powder Diffraction | 1 | 2013 | 3 | 0.100 |
Why?
| | Vaccination | 1 | 2022 | 1378 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 931 | 0.100 |
Why?
| | Postprandial Period | 1 | 2013 | 107 | 0.100 |
Why?
| | Magnetic Phenomena | 1 | 2012 | 10 | 0.100 |
Why?
| | Protein Folding | 1 | 2014 | 281 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2030 | 0.100 |
Why?
| | Vanadates | 1 | 2012 | 14 | 0.100 |
Why?
| | Glutathione | 1 | 2014 | 357 | 0.090 |
Why?
| | Molecular Weight | 1 | 2012 | 334 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5744 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1075 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3290 | 0.090 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2011 | 24 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 800 | 0.090 |
Why?
| | Antimony | 1 | 2011 | 5 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1619 | 0.090 |
Why?
| | Lung | 5 | 2025 | 4065 | 0.090 |
Why?
| | Genome, Plant | 1 | 2011 | 54 | 0.090 |
Why?
| | Droughts | 1 | 2011 | 44 | 0.090 |
Why?
| | Amides | 1 | 2011 | 93 | 0.090 |
Why?
| | Gallbladder Neoplasms | 1 | 2011 | 23 | 0.090 |
Why?
| | Stereoisomerism | 1 | 2011 | 98 | 0.090 |
Why?
| | Protozoan Proteins | 1 | 2011 | 82 | 0.090 |
Why?
| | Pentanones | 1 | 2010 | 3 | 0.090 |
Why?
| | DNA Repair | 2 | 2011 | 230 | 0.090 |
Why?
| | Cognition | 1 | 2018 | 1166 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2024 | 2491 | 0.090 |
Why?
| | Pyrroles | 1 | 2011 | 211 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2024 | 1396 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5417 | 0.080 |
Why?
| | Alloys | 1 | 2010 | 35 | 0.080 |
Why?
| | Streptococcus pneumoniae | 1 | 2011 | 169 | 0.080 |
Why?
| | Tuberculosis, Spinal | 1 | 2009 | 8 | 0.080 |
Why?
| | Polymers | 1 | 2014 | 491 | 0.080 |
Why?
| | Epidural Abscess | 1 | 2009 | 6 | 0.080 |
Why?
| | HeLa Cells | 2 | 2025 | 636 | 0.080 |
Why?
| | Insulin | 1 | 2020 | 2399 | 0.080 |
Why?
| | Magnetics | 1 | 2009 | 47 | 0.080 |
Why?
| | Proto-Oncogenes | 1 | 2009 | 29 | 0.080 |
Why?
| | Quantitative Trait Loci | 1 | 2011 | 381 | 0.080 |
Why?
| | Temperature | 1 | 2012 | 674 | 0.080 |
Why?
| | DNA Methylation | 2 | 2011 | 644 | 0.080 |
Why?
| | Genes, Tumor Suppressor | 1 | 2009 | 86 | 0.080 |
Why?
| | Acetates | 1 | 2009 | 99 | 0.080 |
Why?
| | Prognosis | 1 | 2017 | 4018 | 0.080 |
Why?
| | Biomarkers | 3 | 2017 | 4158 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5115 | 0.070 |
Why?
| | Peptides | 1 | 2014 | 980 | 0.070 |
Why?
| | Kidney Failure, Chronic | 1 | 2013 | 565 | 0.070 |
Why?
| | Cause of Death | 1 | 2010 | 429 | 0.070 |
Why?
| | Copper | 1 | 2008 | 108 | 0.070 |
Why?
| | Protein Binding | 3 | 2024 | 2223 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1250 | 0.070 |
Why?
| | Time Factors | 1 | 2017 | 6792 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 530 | 0.070 |
Why?
| | Adsorption | 2 | 2023 | 147 | 0.060 |
Why?
| | Administration, Mucosal | 1 | 2025 | 2 | 0.060 |
Why?
| | Biological Control Agents | 1 | 2024 | 3 | 0.060 |
Why?
| | RNA | 2 | 2023 | 924 | 0.060 |
Why?
| | Pest Control, Biological | 1 | 2024 | 9 | 0.060 |
Why?
| | Salmonella typhi | 1 | 2005 | 13 | 0.060 |
Why?
| | Healthy Lifestyle | 1 | 2025 | 34 | 0.060 |
Why?
| | Typhoid Fever | 1 | 2005 | 10 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 3953 | 0.060 |
Why?
| | Zinc | 1 | 2008 | 298 | 0.060 |
Why?
| | Prevalence | 1 | 2011 | 2712 | 0.050 |
Why?
| | Nucleotidyltransferases | 1 | 2023 | 28 | 0.050 |
Why?
| | Interleukin-1 | 1 | 2008 | 963 | 0.050 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2023 | 46 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2024 | 112 | 0.050 |
Why?
| | Risk Factors | 2 | 2024 | 10331 | 0.050 |
Why?
| | Chickens | 1 | 2024 | 191 | 0.050 |
Why?
| | Blood Pressure | 2 | 2025 | 1772 | 0.050 |
Why?
| | Inhibitory Concentration 50 | 2 | 2014 | 90 | 0.050 |
Why?
| | Microchemistry | 1 | 2003 | 20 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 808 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2018 | 1054 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1769 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2831 | 0.050 |
Why?
| | Metagenomics | 1 | 2024 | 167 | 0.050 |
Why?
| | Plants | 1 | 2024 | 220 | 0.050 |
Why?
| | Animals, Wild | 1 | 2022 | 58 | 0.050 |
Why?
| | Soil | 1 | 2024 | 231 | 0.050 |
Why?
| | Neutralization Tests | 1 | 2022 | 75 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 260 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2008 | 914 | 0.050 |
Why?
| | Administration, Intranasal | 1 | 2022 | 90 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2023 | 564 | 0.050 |
Why?
| | Models, Animal | 1 | 2024 | 384 | 0.050 |
Why?
| | Administration, Intravesical | 1 | 2021 | 15 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 679 | 0.050 |
Why?
| | Molecular Dynamics Simulation | 1 | 2024 | 238 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 283 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2020 | 4194 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2022 | 84 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1059 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2014 | 485 | 0.050 |
Why?
| | Thermodynamics | 1 | 2023 | 420 | 0.050 |
Why?
| | Reward | 1 | 2024 | 243 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 308 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 107 | 0.040 |
Why?
| | Biosensing Techniques | 1 | 2003 | 126 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2022 | 123 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 288 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.040 |
Why?
| | Feces | 1 | 2024 | 479 | 0.040 |
Why?
| | Hot Temperature | 1 | 2024 | 392 | 0.040 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2021 | 98 | 0.040 |
Why?
| | Base Composition | 1 | 2020 | 77 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 413 | 0.040 |
Why?
| | Medical Illustration | 1 | 2020 | 10 | 0.040 |
Why?
| | Azides | 1 | 2020 | 46 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2024 | 305 | 0.040 |
Why?
| | Ubiquitination | 1 | 2020 | 102 | 0.040 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 133 | 0.040 |
Why?
| | Skin Diseases, Parasitic | 1 | 2020 | 3 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2020 | 158 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 209 | 0.040 |
Why?
| | Autoradiography | 1 | 2019 | 78 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 500 | 0.040 |
Why?
| | Plasticizers | 1 | 2019 | 15 | 0.040 |
Why?
| | Diethylhexyl Phthalate | 1 | 2019 | 15 | 0.040 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2019 | 16 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 71 | 0.040 |
Why?
| | Computational Biology | 1 | 2024 | 645 | 0.040 |
Why?
| | Transferrin | 1 | 2019 | 46 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2020 | 336 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2019 | 154 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1697 | 0.040 |
Why?
| | Public Health | 1 | 2024 | 576 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 514 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 622 | 0.040 |
Why?
| | Esophagus | 1 | 2020 | 255 | 0.040 |
Why?
| | Methylnitrosourea | 1 | 2017 | 7 | 0.040 |
Why?
| | Cell Physiological Phenomena | 1 | 2018 | 19 | 0.040 |
Why?
| | Phenotype | 2 | 2020 | 3199 | 0.040 |
Why?
| | Plant Shoots | 1 | 2017 | 4 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2022 | 886 | 0.040 |
Why?
| | Antibiosis | 1 | 2017 | 10 | 0.040 |
Why?
| | Neuregulin-1 | 1 | 2018 | 46 | 0.040 |
Why?
| | Models, Molecular | 2 | 2014 | 1591 | 0.040 |
Why?
| | Core Binding Factor Alpha 3 Subunit | 1 | 2017 | 6 | 0.040 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 18 | 0.030 |
Why?
| | Disease Resistance | 1 | 2017 | 33 | 0.030 |
Why?
| | Catalase | 1 | 2017 | 131 | 0.030 |
Why?
| | Indoles | 1 | 2020 | 410 | 0.030 |
Why?
| | Depressive Disorder | 1 | 2020 | 380 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 811 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2017 | 264 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 2020 | 374 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 176 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2017 | 150 | 0.030 |
Why?
| | Diet | 1 | 2025 | 1273 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2017 | 171 | 0.030 |
Why?
| | Rifampin | 1 | 2017 | 84 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2017 | 239 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2017 | 76 | 0.030 |
Why?
| | Cytoprotection | 1 | 2017 | 56 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 896 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 736 | 0.030 |
Why?
| | Longevity | 1 | 2018 | 165 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 400 | 0.030 |
Why?
| | Mercury | 1 | 2016 | 41 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1483 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 58 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2008 | 7569 | 0.030 |
Why?
| | Cell Lineage | 1 | 2017 | 347 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2017 | 346 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 513 | 0.030 |
Why?
| | Neural Pathways | 1 | 2017 | 294 | 0.030 |
Why?
| | Imino Sugars | 1 | 2014 | 1 | 0.030 |
Why?
| | Alkaloids | 1 | 2014 | 30 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 86 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 105 | 0.030 |
Why?
| | Optical Devices | 1 | 2014 | 13 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2020 | 895 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 150 | 0.030 |
Why?
| | Siloxanes | 1 | 2014 | 7 | 0.030 |
Why?
| | Tin Compounds | 1 | 2014 | 17 | 0.030 |
Why?
| | Semiconductors | 1 | 2014 | 40 | 0.030 |
Why?
| | Precision Medicine | 1 | 2018 | 426 | 0.030 |
Why?
| | Nerve Net | 1 | 2017 | 258 | 0.030 |
Why?
| | Drug Design | 1 | 2014 | 166 | 0.030 |
Why?
| | Exercise | 1 | 2025 | 2038 | 0.030 |
Why?
| | Triazoles | 1 | 2014 | 147 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 576 | 0.020 |
Why?
| | Fibroblasts | 1 | 2017 | 989 | 0.020 |
Why?
| | DNA Gyrase | 1 | 2011 | 12 | 0.020 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2012 | 94 | 0.020 |
Why?
| | Crops, Agricultural | 1 | 2011 | 31 | 0.020 |
Why?
| | Edible Grain | 1 | 2011 | 49 | 0.020 |
Why?
| | Breeding | 1 | 2011 | 62 | 0.020 |
Why?
| | Hydrolysis | 1 | 2011 | 191 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1092 | 0.020 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 93 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1062 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 142 | 0.020 |
Why?
| | Drug Resistance, Bacterial | 1 | 2011 | 183 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2011 | 523 | 0.020 |
Why?
| | Tubulin | 1 | 2011 | 140 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 1980 | 0.020 |
Why?
| | Laminectomy | 1 | 2009 | 31 | 0.020 |
Why?
| | Glycolysis | 1 | 2011 | 318 | 0.020 |
Why?
| | Paraplegia | 1 | 2009 | 60 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2009 | 44 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 51 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1714 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2011 | 591 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 657 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2011 | 326 | 0.020 |
Why?
| | Carcinogens | 1 | 2009 | 123 | 0.020 |
Why?
| | Binding Sites | 1 | 2011 | 1308 | 0.020 |
Why?
| | Cell Cycle | 1 | 2011 | 601 | 0.020 |
Why?
| | Genome, Human | 1 | 2009 | 424 | 0.020 |
Why?
| | Disease Progression | 1 | 2013 | 2750 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1281 | 0.010 |
Why?
| | Agglutination Tests | 1 | 2005 | 4 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 167 | 0.010 |
Why?
| | Blood | 1 | 2005 | 106 | 0.010 |
Why?
| | Silicon | 1 | 2003 | 16 | 0.010 |
Why?
| | Glucose Oxidase | 1 | 2003 | 26 | 0.010 |
Why?
| | Enzymes, Immobilized | 1 | 2003 | 30 | 0.010 |
Why?
| | Child, Preschool | 2 | 2009 | 11069 | 0.010 |
Why?
| | Gold | 1 | 2003 | 125 | 0.010 |
Why?
| | Surface Properties | 1 | 2003 | 414 | 0.010 |
Why?
| | Equipment Design | 1 | 2003 | 522 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2003 | 480 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1942 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 1019 | 0.010 |
Why?
| | Infant | 1 | 2005 | 9442 | 0.010 |
Why?
|
|
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|